Correlation Between Spyre Therapeutics and FMEGR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and FMEGR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and FMEGR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and FMEGR 3 01 DEC 31, you can compare the effects of market volatilities on Spyre Therapeutics and FMEGR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of FMEGR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and FMEGR.

Diversification Opportunities for Spyre Therapeutics and FMEGR

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Spyre and FMEGR is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and FMEGR 3 01 DEC 31 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FMEGR 3 01 and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with FMEGR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FMEGR 3 01 has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and FMEGR go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and FMEGR

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 4.44 times more return on investment than FMEGR. However, Spyre Therapeutics is 4.44 times more volatile than FMEGR 3 01 DEC 31. It trades about -0.01 of its potential returns per unit of risk. FMEGR 3 01 DEC 31 is currently generating about -0.15 per unit of risk. If you would invest  2,844  in Spyre Therapeutics on September 12, 2024 and sell it today you would lose (200.00) from holding Spyre Therapeutics or give up 7.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy46.88%
ValuesDaily Returns

Spyre Therapeutics  vs.  FMEGR 3 01 DEC 31

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Spyre Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
FMEGR 3 01 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FMEGR 3 01 DEC 31 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for FMEGR 3 01 DEC 31 investors.

Spyre Therapeutics and FMEGR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and FMEGR

The main advantage of trading using opposite Spyre Therapeutics and FMEGR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, FMEGR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FMEGR will offset losses from the drop in FMEGR's long position.
The idea behind Spyre Therapeutics and FMEGR 3 01 DEC 31 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes